As result, many authors have relied only on CD14 and HLA-DR staining to identify monocytic MDSCs in cancer patients, either alone or as a surrogate after first identifying a population of MDSCs that are CD11b+/CD14+/CD15-/HLA-DR-. Here, ITGAM is linked to cancer.